Validation of the International Prognostic Index in Working Formulation group A low-grade non-Hodgkin's lymphoma: Retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry

Haematologica

Volumn 85, Issue 2, 2000, Pages 154-159

  Stelitano, Caterina ^a   Baldini, Luca ^b   Pieresca, Carla ^g   Callea, Vincenzo ^c   Angrilli, Francesco ^d   Clò, Vera ^e   Partesotti, Giovanni ^f   Merli, Francesco ^e   Cavanna, Luigi ^e   Morabito, Fortunato ^a   Federico, Massimo ^e   Brugiatelli, Maura ^a   Silingardi, Vittorio ^e  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Presidio Ospedaliero   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e Ospedale Civile   (Italy)

^f Servizio di Reumatologia   (Italy)

^g NONE

Author keywords

International Prognostic Index; Non Hodgkin's lymphoma; Prognosis; Survival

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; SURVIVAL RATE; THROMBOCYTOPENIA;

LYMPHOMA, NON-HODGKIN; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0034039979     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Horning SJ. Treatment approaches to the low-grade lymphomas. Blood 1994; 83:881-4.
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
3. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49:2112-35.
4. Leonard RC, Hayward RL, Prescott RJ, Wang JX. The identification of discrete prognostic groups in low-grade non-Hodgkin's lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party. Ann Oncol 1991; 2:655-62.
5. Romaguera JE, McLaughlin P, North L, et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. J Clin Oncol 1991; 9:762-9.
6. Cameron DA, Leonard RC, Mao JH, Prescott RJ. Identification of prognostic groups in follicular lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Group. Leuk Lymphoma 1993; 10:89-99.
7. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-94.
8. Bastion Y, Coiffier B. Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients? J Clin Oncol 1994; 12: 1340-2.
9. Lopez-Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E, Rozman C. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 1994; 12:1343-8.
10. Hermans J, Krol AD, van Groningen K, et al. International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood 1995; 86:1460-3.
11. Foussard C, Desablens B, Sensebe L, et al. Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France. Ann Oncol 1997; 8(Suppl 1):49-52.
12. Morrison WH, Hoppe RT, Weiss LM, Picozzi VJ Jr, Horning SJ. Small lymphocytic lymphoma. J Clin Oncol 1989; 7:598-606.
13. Ben-Ezra J, Burke JS, Swartz WG, et al. Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 1989; 73:579-87.
14. Berger F, Felman P, Sonet A, et al. Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct features and outcome. Blood 1994; 83:2829-35.
15. Lister TA, Crowther D, Sutcliff SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds Meeting. J Clin Oncol 1989; 7:1630-6.
16. Litam P, Swan F, Cabanillas F, et al. Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Ann Intern Med 1991; 114:855-60.